Quantitative T2 mapping of lung parenchyma at 9.4 T: A feasibility study in three murine models of interstitial lung disease KU Leuven
PURPOSE: To validate the feasibility of quantitative T2 mapping as a novel, gadolinium-free, preclinical biomarker of interstitial lung disease (ILD). METHODS: Quantitative T2 mapping of lung parenchyma was obtained with multiple-slice multiple-echo readout. A mono-exponential model of magnetization decay was fit to the data to obtain parametric maps of T2 relaxation time in four slices across whole lungs. The measurements were performed in ...